Janelle M. Hoskins

UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters

Janelle M. Hoskins, R. M. Goldberg, Peng Qu et al. · JNCI Journal of the National Cancer Institute · 2007 · 467 citations · Full text

Medicine, Hematology, Pharmacology +17

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

Pu Wang, Qiongzhu Dong, C. Zhang et al. · Oncogene · 2012 · 389 citations

Medicine, Genetics, Oncology +14

The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells

Michelle L. Holland, Jill Panetta, Janelle M. Hoskins et al. · Biochemical Pharmacology · 2006 · 156 citations

Medicine, Pharmacokinetics, Pharmacology +11

Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements

D. Neil Hayes, Amy S. Lucas, Tawee Tanvetyanon et al. · Clinical Cancer Research · 2012 · 149 citations · Full text

Medicine, Oncology, Pharmacology +15

Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype

Howard Gurney, Ma‐Li Wong, Rosemary L. Balleine et al. · Clinical Pharmacology & Therapeutics · 2007 · 142 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +15